Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A retrospective multicenter cohort study of differences in clinical characteristics of Infantile Hemangiomas in preterm and term infants: Prematurity increases risk of permanent cutaneous sequelae.
Bradley FE, Fernández Faith E, Shah SD, Braun M, Pope E, Lara-Corrales I, Witman PM, Harfmann K, Buros Stein A, Frieden IJ. Bradley FE, et al. J Am Acad Dermatol. 2024 Oct 23:S0190-9622(24)03021-4. doi: 10.1016/j.jaad.2024.09.066. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39455031
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma.
Fernández Faith E, Shah S, Witman PM, Harfmann K, Bradley F, Blei F, Pope E, Alsumait A, Gupta D, Covelli I, Streicher JL, Cotton C, Tollefson M, Nguyen H, Hunt R, Moore-Clingenpeel M, Frieden IJ. Fernández Faith E, et al. JAMA Dermatol. 2021 May 1;157(5):566-572. doi: 10.1001/jamadermatol.2021.0469. JAMA Dermatol. 2021. PMID: 33787840 Free PMC article.
Incidence and clinical factors associated with ulceration in infantile hemangiomas.
Fernández Faith E, Shah SD, Braun M, Pope E, Lara-Corrales I, Witman PM, Harfmann K, Bradley F, Keesari R, Jackson K, Hallagan A, Frieden IJ. Fernández Faith E, et al. J Am Acad Dermatol. 2023 Feb;88(2):414-420. doi: 10.1016/j.jaad.2022.10.047. Epub 2022 Oct 28. J Am Acad Dermatol. 2023. PMID: 36404484
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
Tarvin SE, Sherman MA, Kim H, Balmuri N, Brown AG, Chow A, Gewanter HL, de Guzman MM, Huber AM, Kim S, Klein-Gitelman MS, Perron MM, Robinson AB, Sabbagh SE, Savani S, Shenoi S, Spitznagle J, Stingl C, Syverson G, Tory H, Spencer C; Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup. Tarvin SE, et al. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1532-1539. doi: 10.1002/acr.25393. Epub 2024 Aug 14. Arthritis Care Res (Hoboken). 2024. PMID: 38937134